Cargando…
Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing
Engineered mesenchymal stem cells (MSCs) have been investigated extensively for gene delivery and, more recently, for targeted small molecule delivery. While preclinical studies demonstrate the potential of MSCs for targeted delivery, clinical studies suggest that tumor homing of native MSCs may be...
Autores principales: | Prabha, Swayam, Merali, Carmen, Sehgal, Drishti, Nicolas, Emmanuelle, Bhaskar, Nitu, Flores, Magda, Bhatnagar, Shubhmita, Nethi, Susheel Kumar, Barrero, Carlos A., Merali, Salim, Panyam, Jayanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898454/ https://www.ncbi.nlm.nih.gov/pubmed/36747581 http://dx.doi.org/10.1016/j.mtbio.2023.100567 |
Ejemplares similares
-
Enhancing Anticancer Efficacy of Chemotherapeutics Using Targeting Ligand-Functionalized Synthetic Antigen Receptor-Mesenchymal Stem Cells
por: Nethi, Susheel Kumar, et al.
Publicado: (2023) -
Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer
por: Layek, Buddhadev, et al.
Publicado: (2020) -
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022) -
Pharmacokinetic—Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
por: Cheng, Shen, et al.
Publicado: (2021) -
Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)